.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Argus Health
Covington
QuintilesIMS
Deloitte
Federal Trade Commission
Johnson and Johnson
Farmers Insurance
Moodys

Generated: June 23, 2017

DrugPatentWatch Database Preview

Xenon xe-127 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for xenon xe-127 and what is the scope of xenon xe-127 patent protection?

Xenon xe-127
is the generic ingredient in one branded drug marketed by Mallinckrodt and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for xenon xe-127.

Summary for Generic Name: xenon xe-127

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list11
Clinical Trials: see list103
Drug Prices:see low prices
DailyMed Link:xenon xe-127 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt
XENON XE 127
xenon xe-127
GAS;INHALATION018536-001Oct 1, 1982DISCNNoNo► Subscribe► Subscribe
Mallinckrodt
XENON XE 127
xenon xe-127
GAS;INHALATION018536-002Oct 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Cipla
Citi
McKinsey
Harvard Business School
Chinese Patent Office
Queensland Health
Merck
Farmers Insurance
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot